drugset / Trial / NCT02233101
Oral vs. Intravenous TXA Study Proposal: TJA
RandomizedParallel-groupOpen-labelPrevention
Summary
Purpose: Examine oral and intravenous Tranexamic Acid (TXA) to determine whether or not the different routes of drug administration are equivalent in terms of post-operative reduction in hemoglobin, number of transfusions, and post-operative blood loss following TJA surgery. Hypothesis: Oral and intravenous TXA are equivalent routes of drug administration.
Timeline
- Start
- 2014-06
- Primary completion
- 2015-08
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tranexamic Acid | Small molecule | 1 g | Oral |
| Comparator | Tranexamic Acid | Small molecule | 1950 mg | Oral |
Indications
No indication recorded.